Kate Dellorusso
Stock Analyst at LifeSci Capital
(1.46)
# 3,574
Out of 5,022 analysts
21
Total ratings
47.1%
Success rate
-0.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kate Dellorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics | Reiterated: Buy | $13 | $4.39 | +196.13% | 3 | Oct 1, 2026 | |
| UPB Upstream Bio | Reiterated: Buy | $19 | $5.04 | +276.98% | 14 | Sep 1, 2026 | |
| MREO Mereo BioPharma Group | Reiterated: Hold | n/a | $0.3798 | - | 4 | Aug 15, 2026 |
Aclaris Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $13
Current: $4.39
Upside: +196.13%
Upstream Bio
Sep 1, 2026
Reiterated: Buy
Price Target: $19
Current: $5.04
Upside: +276.98%
Mereo BioPharma Group
Aug 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.3798
Upside: -